Israel to offer AstraZeneca’s Evusheld to immunocompromised people
Evusheld has been approved by the US FDA and has proven to be 83 per cent effective in preventing serious illness and death from…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
China’s potential mRNA COVID vaccine weaker against Omicron: Study
The vaccine is being tested in an international phase-III clinical trial
Five-day course of Molnupiravir effective and safe for non-pregnant and unvaccinated COVID-19 adult…
The study has been conducted jointly by Fortis C-DOC, G D Hospital and Diabetes Institute, Jawaharlal Nehru Medical College and…
JB Chemicals and Pharmaceuticals reports revenue growth of 10 per cent to Rs 601 crores in Q3 FY22
As per IQVIA, JB was the fastest-growing company among the top 30 companies for CY 2021
US FDA grants Orphan Drug Designation to BCMA CAR-T cell therapy co-developed by Innovent Biologics…
ODD will accelerate drug development and registration action in the US
Biohaven and Pfizer announce results of rimegepant trial for acute treatment of migraine
This is the fourth positive phase-III study of rimegepant for the acute treatment of migraine, and the first to be conducted in…
Novavax files for Conditional Marketing Authorisation of COVID-19 vaccine in Switzerland
The submission for the regulatory evaluation of the vaccine includes data from two phase-III clinical trials
Novel antibody helps block COVID transmission in cells, finds study
The antibody, FuG1, targets the enzyme furin, which the virus uses for its efficient chain of infections in human cells
Glenmark inks agreement with AstraZeneca to commercialise Pulmicort Respules in Colombia
As per this agreement, AstraZeneca remains the holder of the registration for Pulmicort Respules, and will manufacture the drug.…
ProBioGen signs commercial licence agreement with AstraZeneca for using GlymaxX technology
Following evaluation of the technology under a research license, AstraZeneca will now continue to use GlymaxX and will integrate…